Witryna25 sie 2024 · But the top 20 registered shareholders held 52.42% of Westpac’s ordinary shares—and that’s a controlling stake. The word 'nominee’ or 'custodian’ pops up in 11 of them. There’s an independent wealth management group, a closed-end fund, an investment management firm, and so on. Witryna2 maj 2024 · Imugene shares reached an all-time high of 62.5 cents in November, before shifting to a downhill trend. Based on today’s price, Imugene has a market capitalisation of roughly $1.12 billion with approximately 5.85 billion shares on issue.
Imugene Ltd (ASX:IMU) Share Price - Market Index
WitrynaHER-Vaxx is a B-cell immuno-therapy designed to treat tumours that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. PD1-Vaxx is a B-cell immuno-therapy which aims to induce the body to produce polyclonal antibodies that block PD-1 signalling, and thus produce an anticancer effect similar to ... Witryna24 mar 2024 · Current share price for MSB : $0.925 0.01 (1.07%) Mesoblast Limited (MSB), an ASX-listed company, is an Australian company engaged in the development of regenerative medicine products. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental … how far is reading from london
Imugene Limited (ASX:IMU) - Intelligent Investor
Witryna31 mar 2024 · Shareholders AGM and EGM; Entitlements; Distribution of … WitrynaTop 20 Shareholders; Shareholder Services; Investor FAQs; US Shareholders; … Witryna9 mar 2024 · Here's a couple of extracts from a presentation made by IMU at the time it acquired the Biolife Science technology (ie HER-Vaxx). It was when Axel Hoos and Paul Hopper became involved in the company. The presentation was made in December 2013. HER-Vaxx Phase II trial, was to have covered 78 patients and been completed … highbury wards